Takahisa Imamura Selected Research

Superoxides (Superoxide)

1/2017

Aeromonas sobria serine protease (ASP): a subtilisin family endopeptidase with multiple virulence activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahisa Imamura Research Topics

Disease

11	Neoplasms (Cancer) 09/2022 - 12/2003
11	Inflammation (Inflammations) 01/2021 - 10/2002
8	Periodontitis 07/2019 - 01/2003
5	Infections 01/2022 - 01/2003
5	Sepsis (Septicemia) 01/2017 - 12/2007
5	Disseminated Intravascular Coagulation 01/2017 - 03/2004
5	Periodontal Diseases (Periodontal Disease) 01/2015 - 01/2003
5	Hemorrhage 11/2012 - 01/2003
4	Glomerulonephritis 01/2015 - 03/2004
4	Chronic Periodontitis 06/2006 - 01/2003
3	Hypotension (Low Blood Pressure) 04/2009 - 11/2004
3	Hypersensitivity (Allergy) 11/2004 - 10/2002
2	Neoplasm Metastasis (Metastasis) 09/2022 - 10/2016
2	Tongue Neoplasms (Tongue Neoplasm) 09/2022 - 10/2016
2	Proteinuria 01/2021 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2012
2	Arthus Reaction 01/2019 - 10/2002
2	Blood Coagulation Disorders 01/2017 - 10/2012
2	Bacterial Infections (Bacterial Infection) 11/2005 - 01/2003
1	Castleman Disease (Castleman's Disease) 08/2022
1	Torsades de Pointes (Torsade de Pointes) 08/2022
1	Cardiomyopathies (Cardiomyopathy) 08/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Colitis 12/2017
1	Diarrhea 01/2017
1	Gastroenteritis 01/2017
1	Suppuration 01/2017
1	Carcinoma (Carcinomatosis) 11/2016
1	Stomach Neoplasms (Stomach Cancer) 11/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2015
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2015

Drug/Important Bio-Agent (IBA)

10	Thrombin FDA Link 01/2021 - 10/2002
9	Gingipain Cysteine EndopeptidasesIBA 07/2019 - 01/2003
8	Cysteine Proteases (Cysteine Protease)IBA 07/2019 - 01/2003
7	FibrinIBA 01/2015 - 10/2002
6	Fibrinogen (Factor I)FDA Link 01/2017 - 01/2003
5	Anaphylatoxin C5a ReceptorIBA 01/2021 - 04/2013
5	Serine Proteases (Serine Protease)IBA 01/2017 - 12/2007
4	Thromboplastin (Tissue Factor)IBA 01/2021 - 10/2002
4	Peptides (Polypeptides)IBA 10/2016 - 11/2004
4	Peptide Hydrolases (Proteases)FDA Link 10/2014 - 01/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2008 - 02/2003
3	Complement System Proteins (Complement)IBA 01/2019 - 10/2014
3	AnaphylatoxinsIBA 11/2016 - 04/2013
3	CytokinesIBA 05/2014 - 04/2004
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2012 - 01/2006
3	Blood Proteins (Serum Proteins)IBA 10/2012 - 07/2008
3	Virulence Factors (Pathogenicity Factors)IBA 09/2008 - 11/2005
3	TrypsinIBA 06/2006 - 01/2003
3	EnzymesIBA 11/2004 - 01/2003
2	AngiopoietinsIBA 09/2022 - 10/2016
2	Messenger RNA (mRNA)IBA 09/2022 - 10/2016
2	C-Reactive ProteinIBA 08/2022 - 01/2015
2	PolymersIBA 01/2021 - 12/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 04/2004
2	Matrix Metalloproteinases (MMPs)IBA 10/2016 - 04/2013
2	Amino Acids FDA Link 01/2015 - 01/2003
2	antithrombin III-protease complexIBA 01/2015 - 11/2012
2	Fibrinolysin FDA Link 11/2012 - 01/2006
2	Arginine (L-Arginine)FDA Link 04/2006 - 05/2005
2	Proteins (Proteins, Gene)FDA Link 11/2005 - 01/2003
2	KininsIBA 11/2004 - 01/2003
1	Amyloid (Amyloid Fibrils)IBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	AA amyloidosisIBA 08/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	AlbuminsIBA 01/2021
1	Glucosamine (Dona)IBA 01/2021
1	boric acid (boron oxide hydroxide)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	epimedokoreanin BIBA 07/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Therapeutic UsesIBA 12/2018
1	pirarubicinIBA 12/2018
1	AzoxymethaneIBA 12/2018
1	anthraceneIBA 12/2018
1	Dextran SulfateIBA 12/2018
1	MHC class II transactivator proteinIBA 12/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 12/2017
1	Immunoglobulin A (IgA)IBA 12/2017
1	Complement C5 (Complement 5)IBA 01/2017
1	Superoxides (Superoxide)IBA 01/2017
1	Prothrombin (Factor II)IBA 01/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2015
1	Keratin-6 (Keratin 6A)IBA 01/2015
1	AntigensIBA 01/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2015
1	Lysine (L-Lysine)FDA Link 01/2015

Therapy/Procedure

4	Therapeutics 01/2019 - 01/2003
2	Castration 01/2021 - 11/2012
2	Intravenous Injections 01/2019 - 05/2005
1	Nephroureterectomy 11/2016
1	Cystectomy 11/2016
1	Lasers (Laser) 01/2015